DESCRIPTION: The Joint Task Force on Practice Parameters, which comprises representatives of the American Academy of Allergy, Asthma and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI), formed a workgroup to review evidence and provide guidance to health care provide...
Hormones corticosurrénaliennes,
Antihistaminiques,
Antagonistes des leucotriènes,
Administration par voie nasale,
Administration par voie orale,
Facteurs âges,
Association de médicaments,
Antihistaminiques/usage thérapeutique,
Antagonistes des leucotriènes/usage thérapeutique,
Rhinite allergique saisonnière,
Hormones corticosurrénaliennes/administration et posologie,
Hormones corticosurrénaliennes/usage thérapeutique,
Rhinite allergique saisonnière/diagnostic,
Rhinite allergique saisonnière/traitement médicamenteux
Jouneau, S;
Dres, M;
Guerder, A;
Bele, N;
Bellocq, A;
Bernady, A;
Berne, G;
Bourdin, A;
Brinchault, G;
Burgel, P. R;
Carlier, N;
Chabot, F;
Chavaillon, J. M;
Cittee, J;
Claessens, Y. E;
Delclaux, B;
Deslée, G;
Ferré, A;
Gacouin, A;
Girault, C;
Ghasarossian, C;
Gouilly, P;
Gut-Gobert, C;
Gonzalez-Bermejo, J;
Jebrak, G;
Le Guillou, F;
Léveiller, G;
Lorenzo, A;
Mal, H;
Molinari, N;
Morel, H;
Morel, V;
Noel, F;
Pégliasco, H;
Perotin, J. M;
Piquet, J;
Pontier, S;
Rabbat, A;
Revest, M;
Reychler, G;
Stelianides, S;
Surpas, P;
Tattevin, P;
Roche, N.
Chronic obstructive pulmonary disease (COPD) is the chronic respiratory disease with the most important burden on public health in terms of morbidity, mortality and health costs. For patients, COPD is a major source of disability because of dyspnea, restriction in daily activities, exacerbation, risk of ...
This guideline covers diagnosing and managing bronchiolitis in children. It aims to help healthcare professionals diagnose bronchiolitis and identify if children should be cared for at home or in hospital. It describes treatments and interventions that can be used to help with the symptoms of bronchiolit...
Bressler, B;
Marshall, J. K;
Bernstein, C. N;
Bitton, A;
Jones, J;
Leontiadis, G. I;
Panaccione, R;
Steinhart, A. H;
Tse, F;
Feagan, B.
BACKGROUND & AIMS:: The medical management of ulcerative colitis (UC) has improved through the development of new therapies and novel approaches that optimize existing drugs. Previous Canadian consensus guidelines addressed the management of severe UC in the hospitalized patient. We now present consensu...
This guideline covers recognising, diagnosing and managing bacterial meningitis and meningococcal septicaemia (blood poisoning) in babies, children and young people under 16. It aims to reduce deaths and disability by promoting early recognition of symptoms and timely effective management. For recommenda...
Bronchiolitis obliterans syndrome (BOS) is a major complication of lung transplantation that is associated with poor survival. The International Society for Heart and Lung Transplantation, American Thoracic Society, and European Respiratory Society convened a committee of international experts to describ...
Bronchiolite oblitérante/diagnostic,
Bronchiolite oblitérante/traitement médicamenteux,
Poumon/anatomopathologie,
Azithromycine/usage thérapeutique,
Ciclosporine/usage thérapeutique,
Tacrolimus/usage thérapeutique,
Tomodensitométrie,
Biopsie,
Hormones corticosurrénaliennes/usage thérapeutique,
Volume expiratoire maximal par seconde,
Reflux gastro-oesophagien,
Prise en charge de la maladie,
Facteurs de risque
The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline on glomerulonephritis (GN) is intended to assist the practitioner caring for patients with GN. Two chapters of this guideline focus specifically on nephrotic syndrome in children. Guideline development followed a thoro...
Esta guía constituye una orientación para el manejo de pacientes adultos portadores de
asma bronquial. No es su objetivo establecer estándares de cuidado para pacientes
individuales, los que sólo pueden ser determinados por profesionales competentes en
base a disponer del máximo de información clí...
Elaborar una guía de practica clínica (GPC) para orientar a los profesionales sanitarios en la toma de decisiones y disminuir la variabilidad en la atención a las personas con Esclerosis múltiple (EM). Proporcionar información útil para los pacientes, familiares y cuidadores que les permita conocer...
Sclérose en plaques/thérapie,
Sclérose en plaques/imagerie diagnostique,
Sclérose en plaques/traitement médicamenteux,
Spectroscopie par résonance magnétique/méthodes,
Interféron bêta/usage thérapeutique,
Acétate de glatiramère/usage thérapeutique,
Azathioprine/usage thérapeutique,
Natalizumab/usage thérapeutique,
Chlorhydrate de fingolimod/usage thérapeutique,
Mitoxantrone/usage thérapeutique,
Méthotrexate/usage thérapeutique,
Cyclophosphamide/usage thérapeutique,
Transplantation de cellules souches hématopoïétiques,
Hormones corticosurrénaliennes/usage thérapeutique
Los objetivos de esta GPC son: Contribuir a la disminución de la prevalencia e incidencia de UPP en la población de la Comunidad Valenciana; Aumentar la calidad de los cuidados prestados a las personas con UPP, así como a aquellas con riesgo de desarrollarlas; Promover un estudio epidemiológico descr...
Escarre/épidémiologie,
Escarre/traitement médicamenteux,
Escarre/diagnostic,
Facteurs de risque,
Espagne/épidémiologie,
Programme clinique/organisation et administration,
Gestion de la douleur,
Anti-infectieux locaux/usage thérapeutique,
Hormones corticosurrénaliennes/usage thérapeutique,
Analgésie,
Hypnotiques et sédatifs/usage thérapeutique,
Antibiotiques antinéoplasiques/usage thérapeutique
